| 黄蕊高岩王静谢蠡.超声造影在肝癌射频消融治疗前后的临床价值研究[J].,2012,12(23):4451-4453 |
| 超声造影在肝癌射频消融治疗前后的临床价值研究 |
| Clinical Value of Contrast-enhanced Ultrasonography in Liver Cancer beforeand after Radiofrequency Ablation |
| |
| DOI： |
| 中文关键词: 射频消融 肝癌 实时超声造影 价值 |
| 英文关键词: Radiofrequency ablation Liver cancer Contrast-enhanced ultrasonography Value |
| 基金项目: |
|
| 摘要点击次数: 1056 |
| 全文下载次数: 1005 |
| 中文摘要: |
| 目的：探讨实时超声造影(contrast-enhanced ultrasonography，CEUS)在原发性肝癌射频消融(radiofrequency ablation，RFA)微创
介入前后治疗临床应用价值的研究。方法：通过分析139 例肝癌患者175 个病灶在超声引导下射频消融(RFA)治疗，对病灶数量、
大小、边界、内部回声、造影剂灌注情况进行对比分析，及治疗后与增强CT 结果进行对照。结果：射频消融前，超声造影显示82 个
病灶表现为动脉早期抱球状、弥漫或轻度增强；治疗1-3 个月后超声造影判定89.1％(156／175) 的病灶达到完全消融，10.9％
(19／175)的病灶消融不完全；增强CT 判定84.6％(148／175)的病灶达到完全消融，15.4％(27／175)的病灶消融不完全，治疗后
超声造影检查结果与CT 增强检查结果一致，两者在病灶残留复发的敏感性、特异性、准确性等方面比较无显著性差异，P>0.01。
结论：实时超声造影(CEUS)能准确判断RFA 对肿瘤消融的范围及程度，是一种指导治疗，判定治疗后疗效的新方法，在原发性肝
癌(RFA)微创介入治疗中具有很高的临床应用价值。 |
| 英文摘要: |
| Objective: This article is aimmed to explore the clinical value of contrast-enhanced ultrasonography by examing
before and after the minimally invasive interventional treatment contrast-enhanced ultrasonography on radiofrequency ablation to cure the
disease of Hepatocellular Carcinoma. Methods: To retrospect the 175 cases of infection belonging to 139 Liver cancer patients
respectively, which was under ultrasound guidance to do radiofrequency ablation, to review the ultrasonic imaging before and after the
theraphy, the number, size, border, internal echo and medium infusion are analyzed by comparison of infection. And the CT scanning are
intesified in order to be compared further more. By analyzing 139 cases of liver lesions in 175 patients with ultrasound-guided
radiofrequency ablation (RFA) treatment, the lesion number, size, border, internal echo, contrast agent perfusion were compared, and the
treatment results were compared with contrast-enhanced CT. Real-time ultrasound imaging (CEUS) can accurately determine the scope
of RFA ablation of tumors and extent of treatment is a guide to determine the efficacy of new treatment methods in primary liver cancer
(RFA) in the minimally invasive treatment of high clinical application value. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
